Literature DB >> 19958757

Interleukin-1 receptor antagonist inhibits the release of glutamate, hydroxyl radicals, and prostaglandin E(2) in the hypothalamus during pyrogen-induced fever in rabbits.

Kuo-Feng Huang1, Wu-Tein Huang, Kao-Chang Lin, Mao-Tsun Lin, Ching-Ping Chang.   

Abstract

The present study was attempted to determine whether interleukin-1 receptor antagonist (IL-1ra) pretreatment exerts its antipyresis by reducing organum vasculosum laminae terminalis (OVLT) release of glutamate, hydroxyl radicals and prostaglandin E(2) in rabbits. It was found that systemic administration of lipopolysaccharide induced increased levels of both core temperature and OVLT levels of glutamate, hydroxyl radicals, and prostaglandin E(2). The rise in both the core temperature and OVLT glutamate, hydroxyl radicals and prostaglandin E(2) could also be induced by intracerebroventricular injection of interleukin-1beta. Pretreatment with an intracerebroventricular dose of IL-1ra significantly prevented the lipopolysaccharide or IL-1beta-induced overproduction of glutamate, hydroxyl radicals, and prostaglandin E(2) in OVLT of rabbit's brain. The febrile response caused by systemic administration of lipopolysaccharide or central injection of interleukin-1beta could also be IL-1ra pretreatment-ameliorated. These results indicate that IL-1ra pretreatment may exert its antipyresis by inhibiting the glutamate-hydroxyl radicals-prostaglandin E(2) pathways in the OVLT of rabbit's brain during lipopolysaccharide fever. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958757     DOI: 10.1016/j.ejphar.2009.11.060

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Dietary inflammatory index and memory function: population-based national sample of elderly Americans.

Authors:  Emily Frith; Nitin Shivappa; Joshua R Mann; James R Hébert; Michael D Wirth; Paul D Loprinzi
Journal:  Br J Nutr       Date:  2018-01-24       Impact factor: 3.718

Review 2.  Obesity and episodic memory function.

Authors:  Paul D Loprinzi; Emily Frith
Journal:  J Physiol Sci       Date:  2018-04-17       Impact factor: 2.781

Review 3.  Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Authors:  Tobias Engel; Jonathon Smith; Mariana Alves
Journal:  J Inflamm Res       Date:  2021-07-18

4.  Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation.

Authors:  Mahmoud L Soliman; Mark D Smith; Heidi M Houdek; Thad A Rosenberger
Journal:  J Neuroinflammation       Date:  2012-03-13       Impact factor: 8.322

5.  Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing.

Authors:  Thomas C Rindflesch; Catherine L Blake; Michael J Cairelli; Marcelo Fiszman; Caroline J Zeiss; Halil Kilicoglu
Journal:  J Biomed Semantics       Date:  2018-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.